Author(s): Liao WC, Wang YC, Ma H
Cutaneous leiomyosarcoma (CLM) is a rare soft tissue tumor of smooth muscle derivation. We report the clinical treatment, long-term outcomes, and prognostic findings of CLM in our institution.
Materials and MethodsWe revisited and carried out a retrospective chart review of 16 consecutive patients with CLM treated from 1991 through 2015. Patient demographic data, tumor size, location, previous treatment, follow-up data, and the presence or absence of recurrence were evaluated.
ResultsThere were 6 males and 10 females (mean age, 48.6 years; range, 20–78 years). Clinical follow-up revealed local recurrences in 4 patients 1.3 to 72 months after surgical excision. No distant metastases were observed. We reviewed previously published articles and analyzed the clinical findings, pathologic examinations, and treatments.
ConclusionsSurgical tumor excision with a wide lateral and deep margin is the most appropriate method. Other therapeutic methods such as radio- or chemotherapy provide no significant benefits. We recommend long-term follow-up of patients because recurrence is possible although not common.
Referred From: https://journals.lww.com/annalsplasticsurgery/Abstract/2017/03002/Cutaneous_Leiomyosarcoma__The_Clinical_Experience.6.aspx
Author(s): Hung GY, Horng JL, Chen PC
Author(s): Mayerhofer K, Obermair A, Windbichler G
Author(s): Bharambe BM, Deshpande KA, Surase SG, Ajmera AP
Author(s): Rotmensch J, Bosnyak S, Montag A
Author(s): Yanai H, Wani Y, Notohara K, Takada S, Yoshino T
Author(s): Winchester DS, Hocker TL, Brewer JD
Author(s): Fields JP, Helwig EB
Author(s): Bernstein SC, Roenigk RK
Author(s): Choi JH, Ro JY
Author(s): Starr GF, Dockerty MB
Author(s): Humphreys TR, Finkelstein DH, Lee JB
Author(s): Rao UN, Finkelstein SD, Jones MW
Author(s): Starling J, Coldiron BM
Author(s): Zacher M, Heppt MV, Brinker TJ, Hayani KM, Flaig MJ, et al.
Author(s): Svarvar C, Bohling T, Berlin O